Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Evaluation of the Photoallergy Potential of Atralin Gel
This study has been completed.
Study NCT00603772   Information provided by Coria Laboratories, Ltd.

First Received on January 8, 2008.   Last Updated on May 5, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Additional conditions recognized in this trial
Dermatitis, Photoallergic
More general conditions related to this trial
Dermatitis
Dermatitis, Allergic Contact
Dermatitis, Contact
Hypersensitivity
Hypersensitivity, Delayed
Immune System Diseases
Photosensitivity Disorders
Skin Diseases
Skin Diseases, Eczematous
Interventions listed in this trial
Atralin (tretinoin) gel, 0.05%
Additional drug interventions recognized in this trial
Tretinoin
More general drug interventions related to this trial
Antineoplastic Agents
Dermatologic Agents
Keratolytic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Coria Laboratories, Ltd.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services